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Cancer is a general term that refers to over 100 distinct
pathologies affecting many different tissues and cell types.
However, all forms of cancer are characterised by abnormal
cell growth resulting from inherited or environmentally
induced genomic instability and mutations. Cancer involves
cellular transformation, dysregulation of apoptosis and other
types of cell death, increased proliferation, angiogenesis,
immune evasion, inflammatory responses, and, ultimately,
metastatic spread.
The development of a new class of anticancer drugs
that lacks the toxicity of conventional chemotherapeutic
agents unaffected by common mechanisms of chemoresis-
tance would be a major advance in cancer therapeutics.
Several important chemotherapy agents, such as taxanes,
certain topoisomerase inhibitor, and Vinca alkaloids, were
originally identified from natural sources. Therefore, with
a myriad of organisms yet to be explored, and new tech-
nologies employed, biologically active compounds obtained
from natural products will certainly continue to offer vast
opportunities as sources of new anticancer therapeutic leads.
For this special issue, focusing on natural products as
source for new leads in cancer research and treatment,
we have invited authors to contribute with research and
review articles illustrating and stimulating the continuing
effort in drug discovery and drug development using natural
products as source of bioactive molecules in cancer research
and treatment. Studies relevant to unveiling of potential
targets in cancer biology and the development of innovative
therapeutic strategies were also welcome.
From submissions, nine high-quality manuscripts were
selected covering the above-mentioned topics.
With the aim of providing a good coverage of the state
of the art of this field, this special issue starts with three
review papers, followed by six research papers.The first paper
(by P. A. Ayeka) is a critical review on mushroom immune
modulating potential in cancer. This is followed by another
review regarding anticancer properties of natural products,
especially essential oils (by K. Blowman et al.). The review
third paper dealt with the main characteristics of the studies
using flavonoids in the treatment of hepatocellular carcinoma
in murine models (by E. R. Garc´ıa et al.).
The remaining papers described original research studies
focused on a wide range of topics regarding novel anticancer
actions of natural products from different sources, J.-T. Pai
et al. revealed that suppression lung cancer cells migration
and invasion with propolin C treatment occurred through
EMT regulation. The authors also showed how downregula-
tion EGFR-mediated PI3K/Akt and ERK signaling pathways
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involved in propolin C-regulated EMT in EGFR-mutated
lung cancer cells. L. Yanwei et al. proposed that the traditional
herbal formula NPC01 could exert its antitumor effect by
suppressing the PI3K/Akt/mTOR signaling pathway. The
study performed by M. Valenzuela et al. showed novel
research concerning anticancer properties of selected grape
juice extracts (GJE) by revealing selective cytotoxicity and the
ability to reduce invasiveness of colon cancer cells. H. Li et al.
evaluated tumor growth inhibition of human hepatocellular
carcinoma HepG2 cells in a nude mouse xenograft model
by the total flavonoids from Arachniodes exilis. Next, the
MMP inhibitory effects of flavonoid glycosides from edible
medicinal halophyte Limonium tetragonumwere evaluated in
a study by Bae and colleagues. Finally, the last study in this
special issue, conducted by Y. Zhu and S. Bu, evaluated the
effect of curcumin in humanpancreatic cancer cells, revealing
that it induces autophagy, apoptosis, and cell cycle arrest.
Overall, the current special issue on natural products
as leads for the development of novel anticancer drugs
clearly demonstrates that natural resources are still very
attractive to find and develop novel tools for the treatment of
cancer patients. Taking the phytochemical isolation of novel
compounds and their cellular and molecular investigation in
in vitro cancer cells as a basis, in vivo experimentation and
clinical trials in human cancer patients have to follow to pave
the way for new drugs with better pharmacological features
concerning efficacy to kill tumor cells and safety to spare side
effects towards normal tissues.
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